Sumitomo Mitsui Trust Group Inc. increased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 5.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,523,863 shares of the medical equipment provider's stock after acquiring an additional 73,225 shares during the period. Intuitive Surgical comprises approximately 0.5% of Sumitomo Mitsui Trust Group Inc.'s portfolio, making the stock its 26th biggest holding. Sumitomo Mitsui Trust Group Inc. owned about 0.43% of Intuitive Surgical worth $795,396,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors have also made changes to their positions in ISRG. Atomi Financial Group Inc. increased its stake in shares of Intuitive Surgical by 15.0% in the third quarter. Atomi Financial Group Inc. now owns 1,363 shares of the medical equipment provider's stock worth $669,000 after purchasing an additional 178 shares during the period. Brookstone Capital Management raised its holdings in shares of Intuitive Surgical by 15.2% in the 3rd quarter. Brookstone Capital Management now owns 14,439 shares of the medical equipment provider's stock worth $7,093,000 after buying an additional 1,909 shares in the last quarter. Daymark Wealth Partners LLC boosted its stake in shares of Intuitive Surgical by 0.3% in the 3rd quarter. Daymark Wealth Partners LLC now owns 7,027 shares of the medical equipment provider's stock valued at $3,452,000 after purchasing an additional 24 shares in the last quarter. CWM LLC grew its stake in Intuitive Surgical by 5.3% during the third quarter. CWM LLC now owns 43,152 shares of the medical equipment provider's stock worth $21,199,000 after buying an additional 2,162 shares during the last quarter. Finally, Marcum Wealth LLC increased its holdings in Intuitive Surgical by 1.1% during the 3rd quarter. Marcum Wealth LLC now owns 2,689 shares of the medical equipment provider's stock valued at $1,321,000 after purchasing an additional 29 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
ISRG has been the subject of a number of research analyst reports. Citigroup boosted their target price on shares of Intuitive Surgical from $640.00 to $711.00 and gave the stock a "buy" rating in a research note on Friday, January 24th. Erste Group Bank upgraded Intuitive Surgical from a "hold" rating to a "buy" rating in a research report on Tuesday, November 19th. Oppenheimer restated a "market perform" rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Evercore ISI boosted their price objective on shares of Intuitive Surgical from $490.00 to $530.00 in a research report on Monday, January 27th. Finally, The Goldman Sachs Group set a $604.00 price objective on shares of Intuitive Surgical in a research note on Friday, October 18th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have given a buy rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $613.10.
Check Out Our Latest Research Report on Intuitive Surgical
Intuitive Surgical Trading Down 0.9 %
NASDAQ ISRG traded down $5.52 during midday trading on Friday, hitting $582.98. The company had a trading volume of 1,060,904 shares, compared to its average volume of 1,879,671. The company has a market capitalization of $207.65 billion, a PE ratio of 90.95, a P/E/G ratio of 5.51 and a beta of 1.39. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00. The firm has a 50-day moving average price of $554.03 and a 200-day moving average price of $513.12.
Insider Buying and Selling at Intuitive Surgical
In other news, EVP Robert Desantis sold 376 shares of the business's stock in a transaction on Friday, November 29th. The stock was sold at an average price of $539.00, for a total transaction of $202,664.00. Following the completion of the transaction, the executive vice president now owns 5,506 shares of the company's stock, valued at approximately $2,967,734. The trade was a 6.39 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Jamie Samath sold 94 shares of the firm's stock in a transaction dated Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total value of $53,684.34. Following the completion of the sale, the chief financial officer now directly owns 2,630 shares in the company, valued at $1,502,019.30. This trade represents a 3.45 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 5,940 shares of company stock valued at $3,333,485 in the last ninety days. 0.80% of the stock is currently owned by company insiders.
About Intuitive Surgical
(
Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Featured Stories
Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.